Title: Difference in Quality of Life before the Onset of Psychotic Symptoms in Schizophrenia- A Retrospective Study

Authors: Shivendra Kumar, CRJ Khess, Sanjay Kumar Munda

 DOI: https://dx.doi.org/10.18535/jmscr/v7i2.147

Abstract

Introduction: Quality of life is an important assessment domain in acute and remitted phase of schizophrenia. However considering the view of poor social adjustment and neuropsychological deficits even in prepsychotic phase of illness, it would be important to know how the patients performed on quality of life domains before the onset of symptoms in schizophrenia.

Materials and Methods: A retrospective study was conducted with population of 25 male and 25 female patients of schizophrenia. The study was hospital based and cross sectional assessment of quality of life (QoL) was done prior to onset of illness during best six months of functioning prior to 5 years of onset of illness in both population groups.

Results: QOL was assessed by WHO QOL-BREF in four different domains. In all the domains, no significant difference was found (Domain1, p=.24, Domain 2, p=.71, Domain 3, p=.42, Domain 4, p=.53).

Conclusions: There was no difference in quality of life in male and female patients of schizophrenia before onset of psychotic symptoms. So it can be regarded as quality of life is a different construct and is not solely dependent on neuropsychological deficits or social dysfunction especially prior to onset of symptoms of schizophrenia.

Keywords: Quality of Life (QoL) before onset of psychosis, WHOQOL-BREF, Schizophrenia.

References

  1. Hofer A.A., Hofer S., Baumgartner M., Edlinger M., Hummer G., Kemmler M.A., et al. Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology and side effects. European Psychiatry 2005;20:386–394.
  2. Bobes J, Garcia-Portilla MP, Bascaran MT, Saiz PA, Bousoño M. Quality of life in schizophrenic patients. Dialogues Clin Neurosci. 2007;9:215–26.
  3. Lehman A.F. Instruments for measuring quality of life in mental illnesses. In: Quality of Life in Mental Disorders —Katschnig H, Freeman H, Sartorius N, eds. New York, NY: Wiley 1997;79–94.
  4. Lambert M., Naber D. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 2004;18:
  5. Ho B, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first-episode Schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry 1998;155:1196–1201.
  6. Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 2005;162:441–9.
  7. WHOQOL-Brief. Introduction, Administration, Scoring And Generic Version Of The Assessment Field Trial version 1996.
  8. Nørholm V, Bech P. The WHO quality of life (WHOQOL) questionnaire: Danish validation study. Nord J Psychiatry 2001;55:229–35.
  9. WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551–558.
  10. Shivendra K, Munda SK, Khess CRJ. Gender difference in premorbid adjustment in schizophrenia-a comparative study. Journal of Medical Science and Research 2019;7:123-128.
  11. Shivendra K, Kothari R, Sisodia A, Rathore DMS, Kumar S. Assessment of executive function in first degree relatives of schizophrenia and healthy controls- a comparative study. Scholars Journal of Applied Medical Sciences 2019;7:614-617.

Corresponding Author

CRJ Khess- MD (Psychiatry)

Professor of Psychiatry, Central Institute of Psychiatry, Ranchi- 834006, India